Table 2 Changes from baseline among five haplotype pairs at the end of 12 weeks of treatment with FSC stratified by haplotype pairs
Haplotype pair | Morning PEF (L/min) | FEV1(L) | Albuterol use (puffs/d) | Asthma symptom score |
|---|---|---|---|---|
AC/AC | 108.3 ± 25.1 | 0.46 ± 0.10 | −3.50 ± 2.00 | −0.79 ± 0.16 |
GC/GC | 89.0 ± 18.5 | 0.41 ± 0.09 | −3.57 ± 1.90 | −1.00 ± 0.23 |
GC/GG | 104.4 ± 31.1 | 0.49 ± 0.11 | −4.60 ± 1.89 | −1.20 ± 0.45 |
GC/AC | 111.4 ± 28.1 | 0.42 ± 0.07 | −3.85 ± 2.06 | −1.05 ± 0.51 |
GG/AC | 103.7 ± 27.9 | 0.45 ± 0.05 | −4.33 ± 1.63 | −1.17 ± 0.75 |